Skip to content
PICO Portalanswers from OpenAlex

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy

PaperCitations, authors & open-access status

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy have?

PICO Portalcitation count

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy has 21 citations in the OpenAlex counts PICO Portal stores.

When was Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy published?

PICO Portalyear

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy has 2022 year in the PICO Portal index.

What is the open-access status of Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy?

PICO Portaloa status

Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy has gold oa status in the PICO Portal index.

What is the DOI of Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy?

PICO Portaldoi

The DOI for Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy is on the source record.

What is the PMID of Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy?

PICO Portalpmid

The PMID for Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy is on the source record.

What is the OpenAlex record for Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy?

PICO Portalopenalex

The OpenAlex for Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial